• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
CHEN Xiaoting,CHEN Qiuhe,TU Yalin,PI Rongbiao.New Progress of Serum-and glucocorticoid-Inducible kinase 1 on CNS diseases[J].Journal Of Pharmaceutical Research,2016,35(10):559-568,582[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3767times   Download 3617次 QR Code for this article
Scan with your phone!
血清和糖皮质激素调节蛋白激酶1在CNS疾病中的作用研究新进展
陈晓婷1,陈秋荷1,2,3,涂亚林1,2,3,皮荣标1,2,3,4
Font:Larger+|Default|Smaller-
(1.中山大学药学院药理实验室,广东 广州 510006;2.广东省<中山大学-香港理工大学>抗失智创新药物联合实验室,广东 广州 51006;3.新药成药性评估与评价国家地方联合工程实验室,广东 广州 510006;4. 广东省脑功能重点实验室,广东 广州 510006)
摘要:
血清和糖皮质激素调节蛋白激酶1(SGK1)是1993年在受糖皮质激素刺激的大鼠乳腺癌细胞中发现的一个丝氨酸/苏氨酸蛋白激酶。与多数蛋白激酶不同的是,SGK1不仅受翻译后的磷酸化/去磷酸化调节,而且存在转录水平上的快速调节机制。它具有广泛的生理功能,如调节离子通道,介导细胞增殖、分化、存活及凋亡的信号转导等。它与帕金森病、阿尔茨海默病等多种CNS疾病密切相关,在神经元变性、凋亡过程中起着重要作用。本文将从SGK1的结构、生理功能、与CNS疾病的关系及其抑制剂等方面的新进展作一综述。
关键词:  血清和糖皮质激素调节蛋白激酶1  中枢神经系统疾病  离子通道  信号转导
DOI:10.13506/j.cnki.jpr.2016.10.001
基金项目:国家自然科学基金(No.31371070);广东省国际科技合作项(No.2013B051000038);中央高校基本科研业务费专项资金资助(No.15ykjc08b)
New Progress of Serum-and glucocorticoid-Inducible kinase 1 on CNS diseases
CHEN Xiaoting1,CHEN Qiuhe1,2,3,TU Yalin1,2,3,PI Rongbiao1,2,3,4
(1.Department of Pharmacology & Toxicology,School of Pharmaceutical Sciences,Sun Yat-Sen University,Guangzhou 510006,China;2.International Joint Laboratory of Novel Anti-Dementia Drugs of Guangzhou,Guangzhou 510006,China;3.National and Local United Engineering Lab of Druggability and New Drugs Evaluation,Sun Yat -Sen University,Guangzhou 510006,China;4.Key Labortory of Brain Function of Guangdong,Guangzhou 510006,China)
Abstract:
Serum-and glucocorticoid-Inducible kinase 1 (SGK1),a serine/threonine kinase,was discovered in rat mammary tumor cells which were stimulated by glucocorticoidin 1993.Unlike the case of most of protein kinases, SGK1 is not only regulated by post-translational phosphorylation/dephosphorylation,but also controled by the regulation mechanisms on rapid transcription.SGK1 has multiple physiological functions,such as participating in the regulation of ion channels,mediating the signal transduction of cell proliferation,differentiation,survival,and apoptosis.SGK1 is intimately associated with numerous central nervous system (CNS) diseases, including Parkinson's disease,Alzheimer's disease,and it plays an important role in the process of neuronal degeneration and apoptosis.This review introduced the structure and physiological functions of SGK1,elaborated the new progress of SGK1 on CNS diseases and the new development of its inhibitors.
Key words:  SGK1  CNS diseases  Ion channel  Signal transduction
Today's Visits:465    Total Visits:2383161
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.